Page last updated: 2024-08-23

paclitaxel and Meningioma

paclitaxel has been researched along with Meningioma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daly, AF; Goldbrunner, RH; Hansen, S; Lange, M; Lu, J; Renner, U; Stalla, GK; Theodoropoulou, M; Tichomirowa, MA; Yassouridis, A	1
Heth, JA; Wilson, TJ	1

Other Studies

2 other study(ies) available for paclitaxel and Meningioma

Article	Year
Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel. International journal of cancer, 2008, Oct-15, Volume: 123, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Indoles; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Paclitaxel; RNA, Small Interfering; Spheroids, Cellular; Toll-Like Receptor 4; Tumor Cells, Cultured	2008
Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bevacizumab; Brain; Breast Neoplasms; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel	2012

Article

Year

Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel.

International journal of cancer, 2008, Oct-15, Volume: 123, Issue:8

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Indoles; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Paclitaxel; RNA, Small Interfering; Spheroids, Cellular; Toll-Like Receptor 4; Tumor Cells, Cultured

2008

Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:3

Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bevacizumab; Brain; Breast Neoplasms; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel

2012